Shares of HeartWare International Inc. (NASDAQ:HTWR) saw unusually-high trading volume on Wednesday . Approximately 188,751 shares traded hands during trading, an increase of 8% from the previous session’s volume of 175,272 shares.The stock last traded at $57.97 and had previously closed at $57.96.

HTWR has been the topic of several recent analyst reports. Zacks Investment Research lowered HeartWare International from a “buy” rating to a “hold” rating in a report on Tuesday. Wells Fargo & Co. downgraded HeartWare International from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 29th. Guggenheim began coverage on HeartWare International in a research note on Wednesday, June 8th. They issued a “neutral” rating on the stock. Canaccord Genuity reissued a “buy” rating on shares of HeartWare International in a research note on Saturday, April 30th. Finally, Barclays PLC dropped their price target on HeartWare International from $42.00 to $35.00 and set an “overweight” rating on the stock in a research note on Thursday, May 5th. Fourteen equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. HeartWare International presently has a consensus rating of “Hold” and an average price target of $53.57.

The firm’s market capitalization is $1.02 billion. The company has a 50-day moving average price of $57.78 and a 200-day moving average price of $38.67.

HeartWare International (NASDAQ:HTWR) last issued its quarterly earnings results on Thursday, July 28th. The company reported ($0.43) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.82) by $0.39. During the same period last year, the company posted ($0.47) EPS. The firm had revenue of $68.72 million for the quarter, compared to the consensus estimate of $57.36 million. The business’s revenue was down 6.6% compared to the same quarter last year. On average, equities analysts forecast that HeartWare International Inc. will post ($3.09) EPS for the current fiscal year.

In other news, VP Mark Strong sold 1,875 shares of the stock in a transaction dated Friday, July 22nd. The shares were sold at an average price of $57.71, for a total transaction of $108,206.25. Following the transaction, the vice president now owns 5,388 shares of the company’s stock, valued at approximately $310,941.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Peter F. Mcaree sold 3,125 shares of the stock in a transaction dated Monday, July 11th. The stock was sold at an average price of $57.68, for a total transaction of $180,250.00. Following the transaction, the chief financial officer now directly owns 22,130 shares in the company, valued at approximately $1,276,458.40. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in HeartWare International stock. Nationwide Fund Advisors increased its position in HeartWare International Inc. (NASDAQ:HTWR) by 42.7% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 21,594 shares of the company’s stock after buying an additional 6,458 shares during the period. Nationwide Fund Advisors owned approximately 0.12% of HeartWare International worth $1,088,000 at the end of the most recent quarter.

Heartware International, Inc is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.